Atlas Trials

A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Clinical trial NCT00236067 · COMPLETED

Trial details

NCT number
NCT00236067
Sponsor
Cephalon
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Generalized Anxiety Disorder
Start date
2004-10-01
Enrollment
440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.